Pathophysiology in the clinical course of schizophrenia

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 1, 1998, Pages

  Lieberman, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cavum septum pallucidum; First psychotic episode; Magnetic resonance imaging; Neuropathological progression of schizophrenia; Schizophrenia

Indexed keywords

CLOZAPINE; FLUPHENAZINE; NEUROLEPTIC AGENT;

ADULT; BRAIN CORTEX ATROPHY; BRAIN VENTRICLE DILATATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DOPAMINE METABOLISM; DRUG TOLERANCE; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL DISEASE; HIPPOCAMPUS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SCHIZOPHRENIA; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 0031929835     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199801001-00002     Document Type: Conference Paper

References (17)

1. Bleuler E (1980). The syndrome of schizophrenia: unresolved questions and opportunities for research. Br J Psychiatry 136:413-420.
2. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first-episode schizophrenia. Psychiatry Res 35:1-13.
3. Bogerts B, Lieberman JA, Ashtari M, Bilder R, Degreef G, Lemer G, et al. (1993). Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33:236-246.
4. Chakos MH, Lieberman JA, Bilder RM, Lerner G, Bogerts B, Degreef G, et al. (1994). Increase in caudate nuclei volumes of first episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151:1430-1436.
5. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC (1986). A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 428:120-127.
6. Degreef G, Lantos G, Bogerts B, Ashtari M, Lieberman J (1992). Abnormalities of the septum pellucidum on MRI scans in first episode schizophrenic patients. Am J Neuroradiol 13:835-840.
7. Laruelle M, Abi-Dargham A, Al-Trikti M, Baldwin R, Zea-Ponce Y, Zoghbi S, et al. (1996). Single photon emission tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240.
8. Lieberman JA, Sobel S (1993). Predictors of treatment response and course of schizophrenia. Curr Opin Psychiatry 6:6-63.
9. Lieberman J, Bogerts B, Degreef G, et al. (1992a). Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 149:784-794.
10. Lieberman JA, Alvir JMJ, Woerner M, et al. (1992b). Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital: design, methodology and summary of findings. Schizophr Bull 18:351-371.
11. Lieberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M (1996a). Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 14 (suppl 3):13S-21S.
12. Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JMA, Bilder R (1996b). Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 57 (suppl 9):5-9.
13. May PR, Tuma AH, Dixon WJ (1981). Schizophrenia: a follow-up study of the results of the five forms of treatment. Arch Gen Psychiatry 38:776-784.
14. McGlashan TH (1988). A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 14:515-542.
15. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder? BMJ 295:681-682.
16. 11C] raclopride in the human brain. Synapse 16:255-262.
17. Wyatt RJ (1991). Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17:325-351.